Didn't find what you were looking for?

Feel free to reach out to us.

+91
Or reach us directly
Chat With Us
×

Dr. Abha Kumari

Home> Our Doctors Dr. Abha Kumari
Dr. Abha Kumari

Dr. Abha Kumari

QualificationMBBS , DNB Radiotherapy

SpecialitiesRadiation Oncology

Locations HCG Cancer Center - Kolkata
Experience9 years
Book an Appointment

Introduction

Area of Expertise

  • Experienced in administering high end radiotherapy techniques like 3DCRT, IMRT, VMAT, respiratory gating therapy, IGRT, SRS, SRT, brachytherapy etc    
  •  Extensive experience in research in the field of head and neck cancer and breast cancer    
  • Worked with renowned healthcare institutions like Amrita Institute Medical Science, Kerala, Tata Medical Centre, Kolkata, International Oncology Group, Fortis, Noida and Mahavir Cancer Sansthan, Patna. 

Research & Publications

  •   Rita R, Singh U, Trivedi V, Chauhan R, Kumari A (2017) Determinants of Survival of Cervical Cancer: A Hospital Based Study. Gynecol Obstet 7: 437. doi:10.4172/2161-0932.1000437.    
  • Chatterjee S, Chakraborty S; HYPORT Adjuvant Author Group.
  • Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial. Trials. 2020;21(1):819. Published 2020 Sep 30. doi:10.1186/s13063-020-04751-y    
  • S. Bhusal, S. Chatterjee, S. Chakraborty, A. Kumari, S. Bachianathan, A. Mahato, P. Lal, S. Gupta, P. Solomon, K.M. Das, S. Mandal. PO-1797: Dosimetric analysis of simultaneous integrated boost in the HYPORT Adjuvant Trial (NCT03788213). DOI:10.1016/S0167-8140(21)01815-6. ESTRO 2020 abstract    
  •  Ritesh santosham, Sanjoy Chatterjee, Santam Chakraborty, Avipsa Das, Abha Kumari Hypofractionated Radiotherapy with SIB in Advanced Incurable Breast Cancer -HYPORT B study (NCT03669497). DOI:10.13140/RG.2.2.36479.64160, ESTRO 2020 abstract                              

Medical Breakthrough

  • Clinical Research      Co-investigator in National cancer registry program (NCRP) in Mahavir Cancer Sansthan, Patna    
  • Principal investigator in Quality of life and employment status in head and neck cancer patients from rural area, treated at a tertiary cancer center in tier II city of India: A Prospective cross-sectional study    
  • Co-investigator in a Intensifying radiation treatment in advanced/ poor prognosis laryngeal, hypopharyngeal (LH) and oropharyngeal cancers (OPC) using PET –CT based dose escalation strategies. (INTELHOPE)    
  • Co-investigator in HYPOfractionated Radiation Therapy comparing a standard radiotherapy schedule (over three weeks) with a novel one-week schedule in Adjuvant breast cancer: An open label randomized controlled study (HYPORT- Adjuvant)    
  •  Co-Investigator in Hypofractionated Radiotherapy schedule of 26 Gy in 5 fractions with simultaneous integrated boost (6 Gy) in advanced incurable breast cancer: A prospective Phase I/II study.     Co-Investigator in a prospective, multicenter, randomized, double blind, parallel group study to compare the efficacy and safety of biosimilar cetuximab versus innovator cetuximab in combination with platinum-based chemotherapy in patients with recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (ALK18/ENZ124-CET1)    
  • Co-investigator in a phase III, double-blind, placebo-controlled, randomized trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumors (ADD-Aspirin, breast cancer cohort)    
  • Co-investigator in a Phase III, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti−PD-L1 Antibody) in Combination with Paclitaxel Compared with Placebo with Paclitaxel for Patients with Previously Untreated Inoperable Locally Advanced or Metastatic Triple Negative Breast Cancer (MO39196)      
  • Co-investigator in a Phase II, multicenter, open-label, two-cohort, non-comparative study to assess the efficacy and safety

Practices at

HCG Cancer Center - Kolkata

HCG Cancer Center - Kolkata

Other Doctors

Dr. Sayan Chakraborty
Dr. Sayan Chakraborty

Infectious Diseases

HCG Cancer Center - Kolkata

View Profile Book an Appointment
Dr. Mohammad Masoom Parwez
Dr. Mohammad Masoom Parwez

MBBS, MS (General Surgery), MCh (Surgical Oncology)

Surgical Oncology

HCG Cancer Center - Kolkata

View Profile Book an Appointment
Dr. Moumita Maity
Dr. Moumita Maity

MBBS, MD, ECMO

Radiation Oncology

HCG Cancer Center - Kolkata

View Profile Book an Appointment
Dr. Mrinal kumar Mallick
Dr. Mrinal kumar Mallick

Anesthesia

HCG Cancer Center - Kolkata

View Profile Book an Appointment
Dr. Pallabi Ghosh
Dr. Pallabi Ghosh

Anesthesia

HCG Cancer Center - Kolkata

View Profile Book an Appointment
Dr. Radha Raman Mondal
Dr. Radha Raman Mondal

Surgical Oncology

HCG Cancer Center - Kolkata

View Profile Book an Appointment
Call Icon
WhatsApp Icon
Google Playstore Download logo
App Store Download logo